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EDITORIAL
The structure-function relationship in preeclampsia
In this issue of Kidney International [1], Lafayette and
colleagues bring new information to the field, due to their
established abilities to measure individual determinants of
glomerular filtration rate using sophisticated and validated
morphometric techniques and mathematical modeling
[2, 3].
Eight preeclamptic women underwent post-partum renal
biopsy within 48 hours of cesarean delivery and were
compared to eight non-pregnant controls biopsied at the
time of donation for renal transplantation. A 10% nonsig-
nificant reduction in filtration surface area and a 37%
reduction in single nephron ultrafiltration coefficient
(SNKf) was noted in preeclamptics as compared to control
women. Increased glomerular volume offset decreased
effective peripheral capillary surface area found in pre-
eclamptic as compared to control women. These findings
only emphasize that greater reductions in SNKf would have
been found in preeclampsia if the control group had been
comprised of normal pregnant subjects. Filtration capacity
was reduced in preeclamptic subjects as compared to
normal controls due to the ultrastructural findings of
subendothelial fibrinoid and granular deposits as well as
hypertrophied and swollen endothelial cells.
The timing of the biopsies in this study was crucial given
that ultrastructural changes in preeclampsia can disappear
within the first week following delivery while others repre-
sent a reparative state [4]. The present analysis makes a
strong observation that the hypofiltration found in pre-
eclampsia is due, at least in part, to impaired hydraulic
permeability.
Functional and clinical evaluation in this report stand on
more tenuous ground. The clinical characteristics of the
study group provided are too sparse with regard to parity,
racial background, range of blood pressure, hemoglobin
concentration, platelet count, duration of hospitalization
prior to delivery or the type and dose of antihypertensive
therapies administered. Using a second, different control
group of 12 healthy term gravid women, the investigators
performed para-aminohippurate (PAH) and inulin clear-
ances to determine effective renal plasma flow (ERPF) and
glomerular filtration rate (GFR) approximately four hours
after delivery. The amount of intravenous fluids, anesthe-
sia, or analgesia given was not specified and both groups of
subjects demonstrated extremely low serum albumin levels
(,2 g/liter), suggesting marked intravascular volume ex-
pansion. GFR was depressed in preeclamptic women as
compared to controls while ERPF did not differ between
groups. Of note, different PAH extractions were given to
preeclamptic women (0.76) and controls (0.90) based on
previous work by the investigators in patients with estab-
lished renal insufficiency and nephrotic syndrome [5].
These reference groups demonstrate a level of renal func-
tion that may not be comparable to the present subjects. No
information is available concerning extraction of PAH in
preeclampsia; however, extraction in normal pregnancy is
reported as 0.98 [6].
Although antepartum studies in pregnant women are
difficult to perform, particularly in the setting of pre-
eclampsia, there are no fewer than 23 carefully done
studies, completed prior to 1969, that demonstrate a con-
sistent decrease in both GFR and ERPF of approximately
32 and 24%, respectively [7]. Contemporary studies of ante-
and post-partum GFR and ERPF in untreated preeclamp-
tic women as compared to normal gravids demonstrate
significant reductions in both measures with a greater
magnitude of reduction in GFR [8, 9].
The lack of difference found in both groups in Lafayette
et al’s study [1] is similar to functional studies of central and
systemic hemodynamic measurements reported in treated
and untreated preeclampsia [10]. Eighty-seven untreated
and 47 treated preeclamptics and 10 normal gravidas had
measurements of mean arterial pressure, cardiac index,
pulmonary capillary wedge pressure, and systemic vascular
resistance performed. Cardiac index was decreased in
untreated subjects with preeclampsia as compared to con-
trols (3.3 vs. 4.2 liter/min/m2, P , 0.001) with similar
pulmonary capillary wedge pressures. In contrast, treated
preeclampsia demonstrated similar cardiac indices (4.3 vs.
4.2 liter/min/m2) and greater pulmonary capillary wedge
pressures (7 vs. 5 mm Hg, P , 0.05). Systemic vascular
resistance in treated preeclampsia was intermediary between
healthy gravidas and untreated preeclampsia. Treatment
therefore affects central and systemic hemodynamic profiles
in preeclampsia in comparison to normal pregnancy.
How then, does one interpret the results of the present
study? The morphometric analysis makes an important
contribution with regard to understanding the structural
nature of glomerular dysfunction in preeclampsia. How-
ever, treatment and delivery prior to measurement of GFR
and ERPF make it difficult to come to a conclusion
concerning the functional nature of glomerular dysfunction
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in preeclampsia. It would be a disservice to women with
preeclampsia to suggest, as the authors do “that efforts to
directly alter renal plasma flow, such as by infusion of fluids or
plasma expanders or by use of vasodilators, may not be
beneficial in this disease process.” The current standard of
care in preeclamptic women includes expectant delivery
and judicious use of vasodilator therapy.
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